B cell-derived GABA elicits IL-10<sup>+</sup> macrophages to limit anti-tumour immunity.
Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, Nakano R, Hatae R, Menzies RJ, Sonomura K, Hojo N, Ogawa T, Kobayashi W, Tsutsui Y, Yamamoto S, Maruya M, Narushima S, Suzuki K, Sugiya H, Murakami K, Hashimoto M, Ueno H, Kobayashi T, Ito K, Hirano T, Shiroguchi K, Matsuda F, Suematsu M, Honjo T, Fagarasan S. · 2021
Read B cell-derived GABA elicits IL-10<sup>+</sup> macrophages to limit anti-tumour immunity. by Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, Nakano R, Hatae R, Menzies RJ, Sonomura K, Hojo N, Ogawa T, Kobayashi W, Tsutsui Y, Yamamoto S, Maruya M, Narushima S, Suzuki K, Sugiya H, Murakami K, Hashimoto M, Ueno H, Kobayashi T, Ito K, Hirano T, Shiroguchi K, Matsuda F, Suematsu M, Honjo T, Fagarasan S. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8599023.txt.
Introduction
Zhang and co-authors identify GABA made by B cells as a signal that limits anti-tumor immunity. GABA is best known as a signal in the brain. The team found that active B cells and plasma cells make and release it. They asked what this release does to nearby immune cells.
B cell GABA pushed monocytes to become macrophages that calm inflammation. Those cells made interleukin-10 and weakened killer T cell action. In mice, loss of B cells raised anti-tumor responses. Blocking the enzyme that makes GABA in B cells did the same. The work adds small molecules to the list of tools immune cells use to tune responses.
Catalog record
| CREATOR | Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, Nakano R, Hatae R, Menzies RJ, Sonomura K, Hojo N, Ogawa T, Kobayashi W, Tsutsui Y, Yamamoto S, Maruya M, Narushima S, Suzuki K, Sugiya H, Murakami K, Hashimoto M, Ueno H, Kobayashi T, Ito K, Hirano T, Shiroguchi K, Matsuda F, Suematsu M, Honjo T, Fagarasan S. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity By Baihao Zhang, Alexis Vogelzang, Michio Miyajima, Yuki Sugiura, Yibo Wu, Kenji Chamoto, Rei Nakano, Ryusuke Hatae, Rosemary J. Menzies, Kazuhiro Sonomura, Nozomi Hojo, Taisaku Ogawa Published in: Nature DOI: 10.1038/s41586-021-04082-1 ABSTRACT Small, soluble metabolites not only are essential intermediates in intracellular biochemical processes, but can also influence neighbouring cells when released into the extracellular milieu1–3. Here we identify the metabolite and neurotransmitter GABA as a candidate signalling molecule synthesized and secreted by activated B cells and plasma cells. We show that B cell-derived GABA promotes monocyte differentiation into anti-inflammatory macrophages that secrete interleukin-10 and inhibit CD8+ T cell killer function. In mice, B cell deficiency or B cell-specific inactivation of the GABA-generating enzyme GAD67 enhances anti-tumour responses. Our study reveals that, in addition to cytokines and membrane proteins, small metabolites derived from B-lineage cells have immunoregulatory functions, which may be pharmaceutical targets allowing fine-tuning of immune responses. MAIN Lymphocytes are regulated v a variety of receptor interactions with soluble and cell-bound proteins. However, small metabolites derived from immune cells are also abundant in certain tissues, and many may have signalling potential that has yet to be understood. A growing body of research addresses the flux in metabolic products produced and consumed by different immune cells in various stages of differentiation and activation1–3. We hypothesized that water-soluble metabolites can serve as environmental cues, and mediate interactions between immune cells. GABA IS A B CELL-ASSOCIATED METABOLITE Contrasting homeostatic (non-draining, contralateral; cLN) and activated (draining, ipsilateral; iLN) lymph nodes (LNs) were generated from mice using classic foot-pad immunization with ovalbumin (OVA) protein emulsified in complete Freud’s adjuvant (CFA), and subjected to non-targeted profiling of water-soluble metabolites (Fig. 1a). Principal-component analysis revealed that a strong metabolic shift separated iLNs from cLNs in wild-type (WT) mice (Fig. 1b). Pathway analysis of around 200 metabolites with significantly different abundance between iLNs and cLNs revealed that the alanine, aspartate and glutamate pathway was the strongest metabolic feature differentiating resting and activated immune sites (Fig. 1c). Purine and pyrimidine metabolism and the tricarboxylic acid (TCA) cycle were also strongly associated with immune activation (Fig. 1c and Extended Data Fig. 1a).Fig. 1Metabolic remodelling of immunized LNs and B cell-dependent GABA production.a–e, Mice were injected in the foot pad with OVA + CFA, and iLNs and cLNs were collected for metabolite MS and histology at day 7: WT (n = 11), Cd3–/– (n = 5), muMt–/– (n = 4) and Rag1–/– (n = 3). a, Immunohistochemistry of B cells (B220), T cells (CD3) and myeloid cells (CD11c). Scale bars, 200 µm. b, Principal-component analysis of metabolites in iLNs and cLNs. PC, principal component. c, Pathway analysis of metabolites with significantly different abundance between iLNs and cLNs in WT mice (two-tailed unpaired t-test, P < 0.05). d, Relative Cd3–/– (B cell signature) and muMt–/– (T cell signature) iLN metabolites, showing only metabolites that also differed between iLNs and cLNs in WT mice. e, GABA levels in the indicated cLNs or iLNs, relative to WT cLNs (data are shown as mean ± s.e.m.; two-tailed unpaired t-test: ***P < 0.001, ****P < 0.0001; NS, not significant). f, Correlation of plasma GABA levels with disease activity scores (Simplified Disease Activity Index (SDAI) or Activity Score 28 using C-reactive protein (DAS28-CRP)) and plasma anti-cyclic citrullinated peptide (CCP) antibody levels in patients with rheumatoid arthritis (n = 138). Pearson’s and Spearman’s r and P values (two tailed) are shown. n indicates the number of biological replicates. Data are representative of two experiments (a–e). Exact P values are provided in the Source Data.Source data We assessed the contribution of the main lymphocyte lineages to the metabolic landscape by performing metabolome analyses on activated and resting LNs from immunodeficient mice lacking T cells (Cd3e–/–), B cells (Ighm–/–; referred to hereafter as muMt–/–) or all mature T and B cells (Rag1–/–). Despite the presence of many pathogen-associated molecules in CFA expected to stimulate pattern recognition receptors on myeloid cell subsets, the iLN profile of Rag1–/– mice was similar to that of cLNs, suggesting that lymphocyte activation is the dominant factor contributing to the metabolic shift in this acute inflammatory model (Fig. 1b and Extended Data Fig. 1a). B cells strongly influenced the immunized LN metabolic landscape, as muMt–/– samples were distinct from their WT and Cd3e–/– counterparts (Fig. 1b). The neurotransmitter GABA (γ-aminobutyric acid), not previously known to be synthesized by B cells, was identified as the major metabolite upregulated in iLNs in a B cell-dependent manner with respect to both fold change and P value (Fig. 1d). GABA was also detected in resting cLNs from WT and Cd3e–/– mice, at lower levels (Fig. 1e). However, very little GABA could be detected in LNs from either B cell-deficient mice (muMt–/–) or Rag1–/– mice, indicating that GABA is a signature B cell metabolite, which was confirmed in random forest algorithm analyses (Fig. 1e and Extended Data Fig. 1c). Imaging mass spectrometry (IMS) confirmed co-localization of GABA and the B cell compartment in iLNs (Extended Data Fig. 1b). In contrast to previous studies4,5, we found a positive correlation of plasma GABA levels with disease activity scores and autoantibody titres in patients with rheumatoid arthritis, suggesting that GABA is indicative of B cell activation in humans (Fig. 1f). Together, the results indicate that GABA synthesis in LNs is enhanced by antigenic stimulation, in a B cell-dependent manner. B CELLS SYNTHESIZE AND SECRETE GABA GABA is a major inhibitory neurotransmitter regulating inter-neuron communication. Outside the brain, GABA has been detected in the gut, spleen, liver and pancreas6,7. Quantitative measurements in non-immunized WT mice revealed higher amounts of GABA in peripheral and mucosal LNs than in liver or pancreas, supporting the notion that B cell-enriched lymphoid tissues are important sources of GABA production (Extended Data Fig. 2a). However, aside from pancreatic beta cells, the cellular source of GABA outside neurons remains unknown. Although the GABA precursors glutamine and glutamate were abundant in B cells and myeloid cells, B cells were characterized by an enrichment in GABA, in either resting (contralateral) or activated (ipsilateral) popliteal LNs (Fig. 2a). B cells from bone marrow, spleen, Peyer’s patches and IgA+ plasma cells from the small intestine lamina propria were also characterized by elevated GABA levels (Fig. 2b). Additionally, GABA and other glutamate metabolism components were relatively more abundant in B cells in non-targeted MS analyses of lymphocytes from mouse LNs or peripheral human blood (Extended Data Fig. 2b, c). Analysis of two key enzymes that convert glutamate to GABA showed that transcripts encoding glutamate decarboxylase 67 (GAD67), but not GAD65, were elevated in both mouse and human B cells compared with T cells (Extended Data Fig. 2d, e), suggesting that glutamate metabolism characterizes B-lineage cells in both species.Fig. 2Mouse and human B cells synthesize and secrete GABA.a, MS analysis of glutamine, glutamate and GABA in purified CD4+ T cells, CD8+ T cells, CD11b+ and/or CD11c+ macrophages and dendritic cells (Mf/DC) or B220+ B cells from the cLNs and iLNs of immunized WT mice as in Fig. 1a (n = 3; ND, not done). b, MS-determined GABA levels in B cells from LN (n = 10), spleen (SPL; n = 4), bone marrow (BM; n = 3),